Literature DB >> 20433431

Risk factors for development of cardiovascular complications in patients with chronic renal disease and diabetic nephropathy.

Amra Mataradzija1, Halima Resić, Senija Rasić, Nihad Kukavica, Fahrudin Masnić.   

Abstract

INTRODUCTION: Cardiovascular diseases are the most frequent causes of morbidity and mortality in patients with chronic renal disease. The aim of our paper is to evaluate the risk factors of cardiovascular complications in patients with various stages of chronic renal disease (CRD), with or without diabetes mellitus (DM). PATIENTS AND METHODS: The study included 98 patients with different stages of the CRD, with creatinine clearance <60 ml/min/1.73m2, and laboratory parameters monitored: homocysteine, BNP, cholesterol, LDL, HDL, HbA1c, Body Mass Index (BMI). First group comprised 49 patients with DM, age 50-82 years, M 28/F 21. Second group comprised 49 patients without DM, age 35-80 years, M 18/F 31. The IMT (intima media thickness) was measured by B-mode ultrasonography, and all patients had echocardiography examination done by 2D Doppler ultrasonography.
RESULTS: The IMT values in diabetic patients had statistically significant positive correlation with homocysteine values of r=0.9393, p<0.034, and cholesterol r=0.289, p<0.05, compared to non-diabetics. A significant negative correlation was found between the ejection fraction (EF) and BMI in both groups, more prominent in non-diabetics r=0.289, p<0.044 (diabetics r=0.162, p>0.05). 47.4% of diabetics had arteriosclerotic changes on carotid arteries, 8.5% had stenosis of ACC, and 22.0% had rhythm abnormalities on ECG. A positive correlation between IMT and BMI was found in diabetics, but was not statistically significant r=0.111, p>0.05. In the diabetics group a significantly higher (p<0.05) values of BNP, HbA1c, proteinuria, BMI, and cholesterol were found, and significantly lowered EF (p<0.0001).
CONCLUSION: Risk factors for cardiovascular complications in patients with DM are various, and the most pronounced significance was found in the values of homocysteine, BNP and cholesterol.

Entities:  

Mesh:

Year:  2010        PMID: 20433431      PMCID: PMC5627713          DOI: 10.17305/bjbms.2010.2648

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  20 in total

1.  Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.

Authors:  A Levin; C R Thompson; J Ethier; E J Carlisle; S Tobe; D Mendelssohn; E Burgess; K Jindal; B Barrett; J Singer; O Djurdjev
Journal:  Am J Kidney Dis       Date:  1999-07       Impact factor: 8.860

Review 2.  Anemia and diabetic nephropathy.

Authors:  Eberhard Ritz
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 3.  Arterial remodeling and cardiovascular function in end-stage renal disease.

Authors:  A P Guérin; B Pannier; S J Marchais; F Metivier; G M London
Journal:  Adv Nephrol Necker Hosp       Date:  1997

4.  Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity, the metabolic syndrome, and cardiovascular disease.

Authors:  G L Vega
Journal:  Am Heart J       Date:  2001-12       Impact factor: 4.749

5.  Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.

Authors:  Carmine Zoccali; Francesca Mallamaci; Francesco Antonio Benedetto; Giovanni Tripepi; Saverio Parlongo; Alessandro Cataliotti; Sebastiano Cutrupi; Giuseppe Giacone; Ignazio Bellanuova; Emilio Cottini; Lorenzo Salvatore Malatino
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

Review 6.  Lipid changes and statins in chronic renal insufficiency.

Authors:  Eberhard Ritz; Christoph Wanner
Journal:  J Am Soc Nephrol       Date:  2006-12       Impact factor: 10.121

Review 7.  Diabetes and cardiovascular disease.

Authors:  B V Howard; M F Magee
Journal:  Curr Atheroscler Rep       Date:  2000-11       Impact factor: 5.113

8.  Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.

Authors:  Miranda T Schram; Nish Chaturvedi; Casper Schalkwijk; Francesco Giorgino; Pertti Ebeling; John H Fuller; Coen D Stehouwer
Journal:  Diabetes Care       Date:  2003-07       Impact factor: 19.112

9.  Plasma human brain natriuretic peptide in chronic renal failure.

Authors:  T Akiba; K Tachibana; K Togashi; M Hiroe; F Marumo
Journal:  Clin Nephrol       Date:  1995-11       Impact factor: 0.975

10.  Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size.

Authors:  S J Marchais; A P Guerin; B M Pannier; B I Levy; M E Safar; G M London
Journal:  Hypertension       Date:  1993-12       Impact factor: 10.190

View more
  3 in total

1.  Stepwise increases in left ventricular mass index and decreases in left ventricular ejection fraction correspond with the stages of chronic kidney disease in diabetes patients.

Authors:  Szu-Chia Chen; Jer-Ming Chang; Wan-Chun Liu; Yi-Chun Tsai; Jer-Chia Tsai; Ho-Ming Su; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Exp Diabetes Res       Date:  2011-08-11

2.  Salt-induced changes in cardiac phosphoproteome in a rat model of chronic renal failure.

Authors:  Zhengxiu Su; Hongguo Zhu; Menghuan Zhang; Liangliang Wang; Hanchang He; Shaoling Jiang; Fan Fan Hou; Aiqing Li
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

3.  P wave dispersion and maximum P wave duration are associated with renal outcomes in chronic kidney disease.

Authors:  Jiun-Chi Huang; Shu-Yi Wei; Szu-Chia Chen; Jer-Ming Chang; Chi-Chih Hung; Ho-Ming Su; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.